Package 50201-0421-2

Brand: bromo seltzer

Generic: aspirin, sodium bicarbonate, citric acid
NDC Package

Package Facts

Identity

Package NDC 50201-0421-2
Digits Only 5020104212
Product NDC 50201-0421
Description

10 POUCH in 1 CARTON (50201-0421-2) / 2 TABLET, EFFERVESCENT in 1 POUCH

Marketing

Marketing Status
Marketed Since 2012-07-16
Brand bromo seltzer
Generic aspirin, sodium bicarbonate, citric acid
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "26d12ab7-a1ea-fb79-e063-6394a90a81e4", "openfda": {"nui": ["N0000175833", "N0000175835", "N0000175980", "N0000008556", "N0000175089", "N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0730637092108"], "unii": ["XF417D3PSL", "R16CO5Y76E", "8MDF5V39QO"], "rxcui": ["1536675", "1537012"], "spl_set_id": ["8ff88ee1-e33e-4051-992f-24e2720c48ce"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Coagulation Factor Activity [PE]", "Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Calculi Dissolution Agent [EPC]", "Anti-coagulant [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Acidifying Activity [MoA]", "Calcium Chelating Activity [MoA]", "Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Tower Laboratories Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 POUCH in 1 CARTON (50201-0421-2)  / 2 TABLET, EFFERVESCENT in 1 POUCH", "package_ndc": "50201-0421-2", "marketing_start_date": "20120716"}], "brand_name": "Bromo Seltzer", "product_id": "50201-0421_26d12ab7-a1ea-fb79-e063-6394a90a81e4", "dosage_form": "TABLET, EFFERVESCENT", "pharm_class": ["Acidifying Activity [MoA]", "Alkalinizing Activity [MoA]", "Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Anti-coagulant [EPC]", "Calcium Chelating Activity [MoA]", "Calculi Dissolution Agent [EPC]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Coagulation Factor Activity [PE]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "50201-0421", "generic_name": "ASPIRIN, SODIUM BICARBONATE, CITRIC ACID", "labeler_name": "Tower Laboratories Ltd", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Bromo Seltzer", "active_ingredients": [{"name": "ANHYDROUS CITRIC ACID", "strength": "1000 mg/1"}, {"name": "ASPIRIN", "strength": "325 mg/1"}, {"name": "SODIUM BICARBONATE", "strength": "1916 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20120716", "listing_expiration_date": "20261231"}